Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ESSEX PROPERTY TRUST, INC. (ESS)

  • Business News
  • June 26, 2026, 20:15 UTC
  • 4
  • 1 comments

Essex Property Trust Publishes 2025 Sustainability and Impact Report

Market reaction Comment Full text

EMPLOYERS HOLDINGS, INC. (EIG)

  • Business News
  • June 26, 2026, 20:15 UTC
  • 5
  • 1 comments

Employers Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call

Market reaction Comment Full text

KITE REALTY GROUP TRUST (KRG)

  • Business News
  • June 26, 2026, 20:15 UTC
  • 4
  • 1 comments

Kite Realty Group Publishes Annual Corporate Responsibility Report

Market reaction Comment Full text

RITHM PROPERTY TRUST INC. (RPT)

  • Business News
  • June 26, 2026, 20:15 UTC
  • 5
  • 1 comments

Rithm Property Trust Inc. Declares Second Quarter 2026 Common and Preferred Stock Dividends

Market reaction Comment Full text

IDAHO COPPER CORPORATION (COPR)

  • Business News
  • June 26, 2026, 20:15 UTC
  • 5
  • 1 comments

Coppernico Metals Closes $5.5 Million LIFE Offering

Market reaction Comment Full text

ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND (AFB)

  • Business News
  • June 26, 2026, 20:06 UTC
  • 5
  • 1 comments

ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. REPORTS SECOND QUARTER EARNINGS

Market reaction Comment Full text

Monopar Therapeutics Inc. (MNPR)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 5
  • 1 comments

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Market reaction Comment Full text

UNIVERSE PHARMACEUTICALS INC (UPC)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 3
  • 1 comments

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Market reaction Comment Full text

MONOPAR THERAPEUTICS (MNPR)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 3
  • 1 comments

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Market reaction Comment Full text

LARIMAR THERAPEUTICS, INC. (LRMR)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 3
  • 1 comments

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

Market reaction Comment Full text
  • Previous
  • 3617
  • 3618
  • 3619
  • 3620
  • 3621
  • Next

Search

News categories

  • Technical Exchange News(14645)
  • Event(6229)
  • SEC News(388576)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237217)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin